Fact CheckerSign in

NCT06765434Completed

Effects of Personalized Music Listening in Advanced Alzheimer's

The Effects of Personalized Music Listening on Functional and Cognitive Status in Advanced-Stage Alzheimer's Disease

Source: ClinicalTrials.gov · Last updated 23 Sept 2025

Brief summary (registry, in English)

Recent functional imaging studies have facilitated a better understanding of the neuroplasticity mechanisms underlying the strong and multifaceted effects of music on brain development. For this reason, music is considered a significant factor in improving recall and mood in individuals with dementia. A review investigating the cognitive and behavioral effects of music listening in Alzheimer's disease (AD) reported that personalized (individualized) music listening yielded the best outcomes. This study aims to examine the effects of personalized music activities on functional and cognitive status in individuals with advanced-stage AD.

Status (registry)
Completed
Study type
Interventional
Enrollment
54 (actual)
First submitted
3 Jan 2025
Start date
3 Mar 2025
Primary completion date
15 Sept 2025
Lead sponsor
Okan University
NCT number
NCT06765434

What you commit to

  • Study type: Interventional
  • Participants enrolled: 54
  • From 3 Mar 2025 to the primary completion date, 15 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individuals who have received music education and are able to play an instrument

Other illness

  • Patients with a history of heart disease, hypertension, or diabetes will be excluded from the study.

Other

  • Patients with hearing impairments that could interfere with music listening

Who the study is looking for

  • Aged 65 and over
  • Patients diagnosed with advanced-stage Alzheimer's type dementia according to the diagnostic criteria of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-V)

Age in the registry: 65 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul Okan University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.